1）江苏省卫健委，老年健康科研课题项目，LK2021022，含ω-3 PUFAs免疫营养治疗改善老年晚期消化系统肿瘤患者营养状况及免疫功能的临床研究，2021-01至2023-12、在研、主持

5.1主要论著

1. Xiangyu Su, Chenchun Fu, Fei Liu, Rongrong Bian, Ping Jing.T-cell exhaustion prediction algorithm in tumor microenvironment for evaluating prognostic stratification and immunotherapy effect of esophageal cancer.Environ Toxicol.2023.doi: 10.1002/tox.23887.

2.Xiangyu Su, Guoqing Wang, Shiya Zheng, Chang Ge, Fei Kong, Cailian Wang. Comprehensive Explorations of CCL28 in Lung Adenocarcinoma Immunotherapy and Experimental Validation. J Inflamm Res. 2023,27;16:1325-1342.

3.Chenchun Fu , Shicheng Feng,Sheng Wang, Xiangyu Su. Developmentand validation of a prognostic model for esophageal carcinoma based on immunemicroenvironment using system bioinformatics. CancerMed. 2022 Jun 30.（通讯作者）

4. Chenchun Fu, Jinjun Shi,Xiangyu Su, Shicheng Feng, Sheng Wang. Ultrasound-stimulatedmicrobubbles contributes to radiotherapy in esophageal carcinoma. BiochemCell Biol. 2021,99(6):707-716.（通讯作者）

5.  Jinjun Shi, Chenchun Fu,Xiangyu Su, Shicheng Feng, Sheng Wang. Ultrasound-Stimulated MicrobubblesInhibit Aggressive Phenotypes and Promotes Radiosensitivity of esophagealsquamous cell carcinoma. Bioengineered. 2021,12(1):3000-3013.（通讯作者）

6. Xiangyu Su, Xiaoyao Feng,Chanchan Gao, Guoqing Wang, Lin Liu. ROR promotes the proliferation andmigration of esophageal cancer through regulating miR-145/LMNB2 signal axis. AmJ Transl Res. 2020,12(11):7223-7235.

7. X Su, J Zhang, C Fu, M Xiao, CWang. Recurrent metastatic penile cancer patient with positive PD-L1 expressionobtained significant benefit from immunotherapy: A case report and literaturereview. OncoTargets and Therapy. 2020;13:3319-3324.

8. 苏翔宇, 高潺潺, 侍方方, 周良, 王彩莲. 阿片类药物治疗中重度癌痛病人的营养状况及影响因素分析. 肠外与肠内营养.2019,26(5):261-265.

9. Su X, Gao C, Shi F, Feng X, etal.. A microemulsion co-loaded with Schizandrin A-docetaxel enhances esophagealcarcinoma treatment through overcoming multidrug resistance. Drug Deliv.2017,24:1, 10-19.

10. Su XY, Liu PD, Wu H, et al.Enhancement of radiosensitization by metal-based nanoparticles in cancerradiation therapy. Cancer Biol Med. 2014,11(2):86-91.

11. Su XY, Yin HT, Li SY, et al.Intervention effects of nedaplatin and Cisplatin on proliferation and apoptosisof human tumour cells in vitro. Asian Pac J Cancer Prev. 2012,13(9):4531-6.

12. Mohanad Aldarouish, Xiangyu Su,Jianbing Qiao，et al.Immunomodulatory effects of chemotherapy on blood lymphocytes and survival ofpatients with advanced non-small cell lung cancer. Int J ImmunopatholPharmacol.2019,33.

13. Liu L, Qiu S, Liu Y, Liu Z,Zheng Y, Su X, Chen B, Chen H. Chidamide and 5-flurouracil show a synergisticantitumor effect on human colon cancer xenografts in nude mice. Neoplasma.2016,63(2):193-200.

5.2 科研奖励成果

1.  “消化系恶性肿瘤重组生长激素肿瘤相关安全性及机制研究”（2011B031）获2011年度江苏医学科技进步奖三等奖

2.  “基于超声/磁共振双模式纳米微泡一体化诊疗淋巴瘤制剂的设计及机制研究”（2017-01C-P-03）获2017年江苏肿瘤医学科学技术三等奖

江苏省抗癌协会肉瘤、恶性黑色素瘤专业委员会委员

江苏省癌症医学联盟委员

中国老年医学肿瘤康复分会（CSGOR）青年委员

北京癌症防治学会食管癌专委会青年委员

南京市医学会肿瘤学分会青年委员

中国临床肿瘤学会（CSCO）会员

中国抗癌协会肿瘤标志专业委员会会员

国际肺癌研究协会会员